RESMED INC
SEC EDGAR quarterly and annual company filings
Past bets that played out
These are the clearest thesis calls with observable outcomes, linked back to the original videos.
The provided text is only the header/cover portion of ResMed Inc.’s Form 10-Q for the quarter ended March 31, 2026 (issuer ID, exchange listing, and basic filing checkboxes). It does not include financial statements, MD&A, risk factors, guidance, or any operational/segment details that would enable an earnings-quality read-through or a differentiated trading thesis.
The provided text is only the cover/header portion of ResMed’s Form 10-Q for the quarter ended Dec 31, 2025 (issuer ID, address, exchange listing). It does not include financial statements, MD&A, guidance, segment performance, risks, or any quantitative disclosures needed to form a tradable thesis.
The provided text is only the cover/header portion of ResMed’s Form 10-Q for the quarter ended Dec 31, 2025 (issuer ID, address, exchange listing). It does not include financial statements, MD&A, guidance, segment performance, risks, or any quantitative disclosures needed to form a tradable thesis.
What this channel is watching now
Recent mentions show where this author is concentrating attention right now.
Latest videos and market context
Recent source posts from this author. Create an account to inspect the complete persisted research trail.
GEV 10-Q report for 2026-06-30
The provided excerpt is only the Form 10‑Q cover page for GE Vernova Inc. (GEV) for quarter ended 2026‑06‑30, with no financial statements, MD&A, segment results, guidance, backlog, risks, or other performance details included. As-is, it contains almost no trade-relevant incremental information beyond confirming the filing/period and listing details.
SNBR 10-Q report for 2026-04-04
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
SOUN 10-Q report for 2026-03-31
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
WEAT 10-Q report for 2026-03-31
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
Proof-backed call history
These are recent thesis calls tied to original source content where available.
The provided text is only the header/cover portion of ResMed Inc.’s Form 10-Q for the quarter ended March 31, 2026 (issuer ID, exchange listing, and basic filing checkboxes). It does not include financial statements, MD&A, risk factors, guidance, or any operational/segment details that would enable an earnings-quality read-through or a differentiated trading thesis.
The provided text is only the cover/header portion of ResMed’s Form 10-Q for the quarter ended Dec 31, 2025 (issuer ID, address, exchange listing). It does not include financial statements, MD&A, guidance, segment performance, risks, or any quantitative disclosures needed to form a tradable thesis.
The provided text is only the cover/header portion of ResMed’s Form 10-Q for the quarter ended Dec 31, 2025 (issuer ID, address, exchange listing). It does not include financial statements, MD&A, guidance, segment performance, risks, or any quantitative disclosures needed to form a tradable thesis.
This is the cover/header portion of ResMed Inc.’s Form 10-Q for the quarter ended Sep 30, 2025. The provided excerpt contains no financial results, guidance, risk-factor updates, MD&A, or segment/operational detail, so it is not sufficient to form a high-conviction bullish/bearish view beyond noting an SEC filing/event-risk context.
This is the cover/header portion of ResMed Inc.’s Form 10-Q for the quarter ended Sep 30, 2025. The provided excerpt contains no financial results, guidance, risk-factor updates, MD&A, or segment/operational detail, so it is not sufficient to form a high-conviction bullish/bearish view beyond noting an SEC filing/event-risk context.
The provided excerpt is only the cover-page portion of ResMed’s FY2025 Form 10-K (fiscal year ended June 30, 2025). It contains identification/registration details (issuer status, exchange listing, ticker RMD) but no operating results, guidance, risk updates, or segment commentary. As-is, it does not support a directional investment view.
About this channel
Channel bio, source link, and public-market context from YouTube.
SEC EDGAR quarterly and annual company filings
Most recognized assets
Unlock the full track record
Create an account to inspect the complete author history, trust-weighted rankings, and persisted research across authors, theses, and assets.